Metoprolol Succinate Extended-Release Tablets — Class II drug recall D-0355-2026
Ongoing recall by Teva Pharmaceuticals USA, Inc, reported 2026-03-11, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0355-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Inc, Parsippany, NJ, United States |
| Recall initiated | 2026-01-29 |
| Classified | 2026-02-27 |
| Reported by FDA | 2026-03-11 |
| Distributed | Nationwide (US) |
| Quantity | 67,043 bottles |
| Reason classes | specification failure |
| NDC | 45963-0676, 45963-0676-11, 45963-0676-96, 45963-0677, 45963-0677-11, 45963-0677-96, 45963-0678, 45963-0678-11, 45963-0709, 45963-0709-11, 45963-0709-96 |
| Expiration dates | 2027-01 |
Product
Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0355-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.